Patents Assigned to New England Biolabs
  • Publication number: 20150240310
    Abstract: Methods and compositions are described for detecting hydroxymethylated nucleotides (hmNs) in a polynucleotide preparation with a view to mapping the location of hmNs in a genome, quantifying the occurrence of hmNs at selected loci and correlating the occurrence of hmNs with gene expression and phenotypic traits. Embodiments describe the use of modifying enzymes together with site-specific endonucleases to detect the hmNs.
    Type: Application
    Filed: April 14, 2015
    Publication date: August 27, 2015
    Applicant: NEW ENGLAND BIOLABS, INC.
    Inventors: Jurate Bitinaite, Romualdas Vaisvila, Sriharsa Pradhan, Yu Zheng, Richard J. Roberts, Hang-Gyeong Chin, Devora Cohen-Karni, Christopher Noren, Elisabeth A. Raleigh, Geoffrey Wilson
  • Publication number: 20150240293
    Abstract: Methods are provided for a rapid, low cost approach to monitoring an amplification reaction. This includes monitoring the progress of isothermal or PCR amplification reactions to completion using pH-sensitive dyes that are either colored or fluorescent. Compositions are described that include a mixture of a DNA polymerase, deoxyribonucleotide triphosphate and a weak buffer of less than 1 mM Tris or equivalent or no buffer.
    Type: Application
    Filed: April 7, 2015
    Publication date: August 27, 2015
    Applicant: NEW ENGLAND BIOLABS, INC.
    Inventors: Nathan Tanner, Yinhua Zhang, Thomas C. Evans
  • Patent number: 9109226
    Abstract: Compositions and methods are provided for inhibiting a polymerase from replicating non target DNA at a temperature below the amplification reaction temperature. The inhibitor is a synthetic nucleic acid which is single stranded but folds to form at least one double stranded region designed to melt at a temperature which is lower than the amplification reaction temperature, and at least one single stranded region where the single stranded region at the 5? end contains at least one uracil or inosine and optionally a sequence at the 3? end contains one or more derivative nucleotide or linkages.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: August 18, 2015
    Assignee: New England Biolabs, Inc.
    Inventors: Jennifer Ong, Donald Johnson, Thomas C. Evans, Lucia Greenough
  • Publication number: 20150218530
    Abstract: 5-methylpyrimidine oxygenases and their use in the modification of nucleic acids are described.
    Type: Application
    Filed: April 20, 2015
    Publication date: August 6, 2015
    Applicant: NEW ENGLAND BIOLABS, INC.
    Inventors: Yu Zheng, Lana Saleh, June Pais, Nan Dai, Richard J. Roberts, Ivan R. Correa, JR., Megumu Mabuchi, Romualdas Vaisvila
  • Patent number: 9074196
    Abstract: Compositions and methods are provided for enzymes with altered properties that involve a systematic approach to mutagenesis and a screening assay that permits selection of the desired proteins. Embodiments of the method are particularly suited for modifying specific properties of restriction endonucleases such as star activity. The compositions includes restriction endonucleases with reduced star activity as defined by an overall fidelity index improvement factor.
    Type: Grant
    Filed: January 8, 2013
    Date of Patent: July 7, 2015
    Assignee: New England Biolabs, Inc.
    Inventors: Zhenyu Zhu, Aine Quimby, Shuang-Yong Xu, Shengxi Guan, Hua Wei, Penghua Zhang, Dapeng Sun, Siu-hong Chan
  • Patent number: 9074197
    Abstract: Compositions and methods are provided for enzymes with altered properties that involve a systematic approach to mutagenesis and a screening assay that permits selection of the desired proteins. Embodiments of the method are particularly suited for modifying specific properties of restriction endonucleases such as star activity. The compositions includes restriction endonucleases with reduced star activity as defined by an overall fidelity index improvement factor.
    Type: Grant
    Filed: January 8, 2013
    Date of Patent: July 7, 2015
    Assignee: New England Biolabs, Inc.
    Inventors: Zhenyu Zhu, Aine Quimby, Shuang-Yong Xu, Shengxi Guan, Hua Wei, Penghua Zhang, Dapeng Sun, Siu-hong Chan
  • Patent number: 9074243
    Abstract: Compositions and methods are provided for quantitative detection of amplification products, the methods being suitable for multiplexing. A first oligonucleotide that includes a primer sequence for priming an amplification reaction and also is labeled with a fluorescent label or quencher is mixed with a second oligonucleotide which has a sequence suitable for hybridizing to a portion of the first oligonucleotide and has a fluorescent label if the first oligonucleotide has a quencher or a quencher if the first oligonucleotide has a fluorescent label; and a third nucleotide which includes some or all the primer sequence contained in the first oligonucleotide but is not labeled, the first and third oligonucleotide being combined in a molar ratio of 2.8 to 8.2.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: July 7, 2015
    Assignee: New England Biolabs, Inc.
    Inventors: Nathan Tanner, Yinhua Zhang, Thomas C. Evans
  • Patent number: 9074249
    Abstract: Compositions and methods are provided for quantitative detection of amplification products, the methods being suitable for multiplexing. A first oligonucleotide that includes a primer sequence for priming an amplification reaction and also is labeled with a fluorescent label or quencher is mixed with a second oligonucleotide which has a sequence suitable for hybridizing to a portion of the first oligonucleotide and has a fluorescent label if the first oligonucleotide has a quencher or a quencher if the first oligonucleotide has a fluorescent label; and a third nucleotide which includes some or all the primer sequence contained in the first oligonucleotide but is not labeled, the first and third oligonucleotide being combined in a molar ratio of 2.8 to 8.2.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: July 7, 2015
    Assignee: New England Biolabs, Inc.
    Inventors: Nathan Tanner, Yinhua Zhang, Thomas C. Evans
  • Patent number: 9040239
    Abstract: 5-methylpyrimidine oxygenases and their use in the modification of nucleic acids are described.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: May 26, 2015
    Assignee: New England Biolabs, Inc.
    Inventors: Yu Zheng, Lana Saleh, June Pais, Nan Dai, Richard J. Roberts, Ivan R. Correa, Jr., Megumu Mabuchi, Romualdas Vaisvila
  • Patent number: 9034606
    Abstract: Methods are provided for a rapid, low cost approach to monitoring an amplification reaction. This includes monitoring the progress of isothermal or PCR amplification reactions to completion using pH-sensitive dyes that are either colored or fluorescent. Compositions are described that include a mixture of a DNA polymerase, deoxyribonucleotide triphosphate and a weak buffer of less than 1 mM Tris or equivalent or no buffer.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: May 19, 2015
    Assignee: New England Biolabs, Inc.
    Inventors: Nathan Tanner, Yinhua Zhang, Thomas C. Evans
  • Patent number: 9034625
    Abstract: Compositions and methods are provided for enzymes with altered properties that involve a systematic approach to mutagenesis and a screening assay that permits selection of the desired proteins. Embodiments of the method are particularly suited for modifying specific properties of restriction endonucleases such as star activity. The compositions includes restriction endonucleases with reduced star activity as defined by an overall fidelity index improvement factor.
    Type: Grant
    Filed: January 8, 2013
    Date of Patent: May 19, 2015
    Assignee: New England Biolabs, Inc.
    Inventors: Zhenyu Zhu, Aine Quimby, Shuang-Yong Xu, Shengxi Guan, Hua Wei, Penghua Zhang, Dapeng Sun, Siu-hong Chan
  • Patent number: 9034597
    Abstract: Methods and compositions are described for detecting hydroxymethylated nucleotides (hmNs) in a polynucleotide preparation with a view to mapping the location of hmNs in a genome, quantifying the occurrence of hmNs at selected loci and correlating the occurrence of hmNs with gene expression and phenotypic traits. Embodiments describe the use of modifying enzymes together with site-specific endonucleases to detect the hmNs.
    Type: Grant
    Filed: August 25, 2010
    Date of Patent: May 19, 2015
    Assignee: New England Biolabs, Inc.
    Inventors: Jurate Bitinaite, Romualdas Vaisvila, Sriharsa Pradhan, Yu Zheng, Richard J. Roberts, Devora Cohen-Karni, Christopher Noren, Elisabeth A. Raleigh, Geoffrey Wilson, Hang-Gyeong Chin
  • Publication number: 20150132750
    Abstract: 5-methylpyrimidine oxygenases and their use in the modification of nucleic acids are described.
    Type: Application
    Filed: March 14, 2013
    Publication date: May 14, 2015
    Applicant: NEW ENGLAND BIOLABS, INC.
    Inventors: Yu Zheng, Lana Saleh, June Pais, Nan Dai, Richard J. Roberts, Ivan R. Correa, JR., Megumu Mabuchi, ROMUALDAS VAISVILA
  • Patent number: 9029087
    Abstract: Compositions, methods and related uses are provided relating to cleaving modified DNA. For example, a set of DNA fragments obtainable by enzymatic cleavage of a large DNA is described where at least 50% are similarly sized and have a centrally positioned modified nucleotide. In addition, an enzyme preparation is provided that includes one or more enzymes that recognize a modified nucleotide in a DNA and cleave the DNA at a site that is at a non-random distance from the modified nucleotide. The one or more enzymes are further characterized by an N-terminal conserved domain with greater than 90% amino acid sequence homology to WXD(X)10YXGD. The related uses include creating a methylome, methods of purifying DNA fragments containing a modified nucleotide and diagnostic applications.
    Type: Grant
    Filed: August 16, 2013
    Date of Patent: May 12, 2015
    Assignee: New England Biolabs, Inc.
    Inventors: Yu Zheng, Richard J. Roberts
  • Patent number: 9023634
    Abstract: Compositions and methods are provided for enzymes with altered properties that involve a systematic approach to mutagenesis and a screening assay that permits selection of the desired proteins. Embodiments of the method are particularly suited for modifying specific properties of restriction endonucleases such as star activity. The compositions includes restriction endonucleases with reduced star activity as defined by an overall fidelity index improvement factor.
    Type: Grant
    Filed: January 8, 2013
    Date of Patent: May 5, 2015
    Assignee: New England Biolabs, Inc.
    Inventors: Zhenyu Zhu, Aine Quimby, Shuang-Yong Xu, Shengxi Guan, Hua Wei, Penghua Zhang, Dapeng Sun, Siu-hong Chan
  • Publication number: 20150119261
    Abstract: Methods and compositions are provided for enriching for target sequences from a population of nucleic acids, that includes: combining in solution, a population of nucleic acids and a target isolation probe wherein the target isolation probe comprises an affinity binding domain; permitting a single stranded region of the target isolation probe to hybridize to all or a portion of a target sequence in the population of nucleic acids; selectively immobilizing the hybridized nucleic acids from the population containing the target sequences by associating the target isolation probe with a capture domain and removing unbound material; removing non-target sequences from the 3? end of the target sequence by means of one or more 3? exonucleases thereby generating a blunt ended duplex or a staggered end at the 3? end of the target sequence; optionally ligating a 3? duplex adaptor or a duplex end of a hairpin adaptor to the 3? end of the target sequence and the 5? end of the target isolation probe; extending the 3? end o
    Type: Application
    Filed: December 11, 2014
    Publication date: April 30, 2015
    Applicant: NEW ENGLAND BIOLABS, INC.
    Inventor: Cynthia Richard
  • Publication number: 20150104790
    Abstract: Compositions and methods are provided for improved reverse transcriptases and their uses in reverse transcription where the improvement may include increased temperature, increased salt, increased activity and/or increased dUTP tolerance.
    Type: Application
    Filed: October 16, 2014
    Publication date: April 16, 2015
    Applicant: NEW ENGLAND BIOLABS, INC.
    Inventors: Yinhua Zhang, Thomas C. Evans, JR.
  • Patent number: 8993298
    Abstract: Novel proteins having DNA polymerase are described which have utility in amplification reactions and have improved properties over Bst polymerase such as for example enhanced reverse transcriptase activity.
    Type: Grant
    Filed: August 31, 2012
    Date of Patent: March 31, 2015
    Assignee: New England Biolabs, Inc.
    Inventors: Jennifer Ong, Thomas C. Evans, Jr., Nathan Tanner
  • Patent number: 8981067
    Abstract: Compositions relating to a combination of two types of separation matrix; and to variant host cells which contain at least one essential host protein that is fused to an affinity binding tag or has been mutated to replace at least two of a plurality of histidines or basic amino acids are provided. Methods are also provided that relate to isolating a recombinant protein from a lysate.
    Type: Grant
    Filed: August 26, 2011
    Date of Patent: March 17, 2015
    Assignee: New England Biolabs, Inc.
    Inventors: James C. Samuelson, Carine Robichon-Iyer, Jianying Luo
  • Patent number: 8980553
    Abstract: Compositions and methods are provided for enriching non-target polynucleotides from a mixture of non-target and target polynucleotides where differences between the target polynucleotides and the non-target polynucleotides include the extent of modified bases that are present in a greater density in the target polynucleotides than in the non-target polynucleotides. This permits the target polynucleotides to be selectively and rapidly bound to an affinity matrix such as affinity protein-coated magnetic beads providing enrichment of the non-target polynucleotides in the supernatant. One use of this enrichment is to remove human genomic DNA from a mixture of DNAs obtained from human tissue samples to enrich for polynucleotides in a microbiome so as to characterize the microbiome by DNA sequencing.
    Type: Grant
    Filed: March 30, 2012
    Date of Patent: March 17, 2015
    Assignee: New England Biolabs, Inc.
    Inventors: George R. Feehery, Fiona Stewart, James McFarland, Sriharsa Pradhan